4013:TADAWULDr. Sulaiman Al-Habib Medical Services Group Co. Analysis

Dr. Sulaiman Al Habib Medical Services Group is trading well below its short‑ and long‑term moving averages (20‑day SMA ~227, 50‑day SMA ~241, 200‑day SMA ~252) with a bearish MACD crossover and an RSI around 34, suggesting oversold conditions but a still‑negative momentum. Volatility is elevated at roughly 29% over the past 30 days and beta is effectively neutral, indicating price swings are driven more by company‑specific factors than market moves. The stock appears significantly overvalued relative to its discounted cash‑flow fair value (~120 SAR) and peers (PE ~32 vs industry ~27), while the dividend yield of 1.85% is backed by a 72% payout ratio despite negative free cash flow and a high debt‑to‑equity ratio above 100%. Recent expansion with the inauguration of a new day‑surgery centre in Dubai adds a growth catalyst, complementing an 8.8% revenue growth and strong ROE near 30%.